Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain
Type of Study: Animal Study
Year of Pub: 2024
Minor Cannabinoids as an Emerging Frontier for Pain Relief
Type of Study: Meta-analysis
Year of Pub: 2024
Use of phytocanabinoids in animal models of Parkinson's disease: Systematic review
Type of Study: Meta-analysis
Year of Pub: 2024
Effects of cannabinoids on resting state functional brain connectivity: A systematic review
Type of Study: Clinical Meta-analysis
Year of Pub: 2023
Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach
Type of Study: Clinical Trial
Year of Pub: 2023
Molecular pathway and structural mechanism of human oncochannel TRPV6 inhibition by the phytocannabinoid tetrahydrocannabivarin
Type of Study: Laboratory Study
Year of Pub: 2023
Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling Pathway
Type of Study: Laboratory Study
Year of Pub: 2023
Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
Type of Study: Meta-analysis
Year of Pub: 2022
A Systematic Review of Medical Cannabinoids Dosing in Human
Type of Study: Clinical Meta-analysis
Year of Pub: 2022
Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes
Type of Study: Laboratory Study
Year of Pub: 2022
Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents
Type of Study: Animal Study
Year of Pub: 2022
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
Type of Study: Meta-analysis
Year of Pub: 2022
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson's Disease: A Systematic Literature Review of Pre-Clinical Studies
Type of Study: Meta-analysis
Year of Pub: 2022
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
Type of Study: Laboratory Study
Year of Pub: 2021
Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
Type of Study: Meta-analysis
Year of Pub: 2021
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
Type of Study: Meta-analysis
Year of Pub: 2021
Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
Type of Study: Animal Study
Year of Pub: 2021
Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro
Type of Study: Laboratory Study
Year of Pub: 2021
Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
Type of Study: Meta-analysis
Year of Pub: 2021
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
Type of Study: Laboratory Study
Year of Pub: 2021
The Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin, and 11-nor-9-carboxy-∆9-THC in Hair
Type of Study: Laboratory Study
Year of Pub: 2021
Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
Type of Study: Meta-analysis
Year of Pub: 2020
Antioxidant and antimicrobial activity of two standardized extracts from a new Chinese accession of non-psychotropic Cannabis sativa L
Type of Study: Laboratory Study
Year of Pub: 2020
High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain
Type of Study: Animal Study
Year of Pub: 2020
Synthesis of the Major Mammalian Metabolites of THCV
Type of Study: Meta-analysis
Year of Pub: 2020
Cannabinoids and Chronic Liver Diseases
Type of Study: Meta-analysis
Year of Pub: 2020
Beneficial effects of the phytocannabinoid Δ 9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
Type of Study: Animal Study
Year of Pub: 2020
Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath
Type of Study: Laboratory Study
Year of Pub: 2020
Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes
Type of Study: Laboratory Study
Year of Pub: 2019
Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence
Type of Study: Animal Study
Year of Pub: 2019
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Type of Study: Meta-analysis
Year of Pub: 2019
Effects of non‐euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice
Type of Study: Laboratory Study
Year of Pub: 2018
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
Type of Study: Double Blind Clinical Trial
Year of Pub: 2016
The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers
Type of Study: Double Blind Clinical Trial
Year of Pub: 2016
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
Type of Study: Double Blind Clinical Trial
Year of Pub: 2016
Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers
Type of Study: Double Blind Clinical Trial
Year of Pub: 2015
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
Type of Study: Meta-analysis
Year of Pub: 2015
The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects
Type of Study: Animal Study
Year of Pub: 2015
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.
Type of Study: Animal Study
Year of Pub: 2013
Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile
Type of Study: Laboratory Study
Year of Pub: 2013
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats
Type of Study: Animal Study
Year of Pub: 2013
Δ8-Tetrahydrocannabivarin Prevents Hepatic Ischaemia/Reperfusion Injury by Decreasing Oxidative Stress and Inflammatory Responses Through Cannabinoid CB2 Receptors
Type of Study: Animal Study
Year of Pub: 2012
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
Type of Study: Animal Study
Year of Pub: 2011
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Type of Study: Meta-analysis
Year of Pub: 2009
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol
Type of Study: Double Blind Clinical Trial
Year of Pub: 2009
The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum
Type of Study: Laboratory Study
Year of Pub: 2008
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo
Type of Study: Animal Study
Year of Pub: 2007
Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study
Type of Study: Clinical Trial
Year of Pub: 2001
Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of Hashish
Type of Study: Laboratory Study
Year of Pub: 1969